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Introduction. In the last years, the global prevalence of the moderate-severe renal dysfunction 
has gradually increased to an epidemic state. The risk of chronic kidney disease occurrence in 
heart failure (HF) is not well established, but kidney dysfunction is very often encountered in HF 
patients and is associated with a poor prognosis. Thyroid hormone, also, has been identified as a 
risk factor for the heart disease progression and development. 
Aim of the study. To investigate whether thyroid function is associated with chronic kidney 
disease in heart failure patients. 
Materials and methods. This observational cohort study included 25 patients with reduced 
ejection fraction heart failure CKD. Routine biochemistry, including Cysteine C, thyroid 
stimulating hormone(TSH) and proteinuria were measured. Glomerular filtration rate (GFR) was 
estimated by the CKD-EPI CYSTETIN C based formula adjusted for Body Surface Area. We 
divided patients into two groups according to estimated GFR: ≥60ml/min (CKD stages I-II 
KDOQI); and <60ml/min(CKD stages III-V KDOQI). 
Results. Among 26 adult participants, 15 had moderate-to-severe decrease in eGFR<60 ml/min 
with a mean TSH level of 7.4±3.28 UN/ml(p<0.05); Cystetine C of 1.15±0.07 mg/L; mean 
ejection fraction (EF) of 43.4±2.84% level; uric acid level 446.2±81.27mmol/L; total cholesterol 
– 7.95±3.37 mmol/L; triglycerides 2.19 mmol/L and 0.12 g/l proteins in urine. 11 subjects had 
elevated, normal or mild decrease in eGFR≥60 ml/min; a mean TSH level of 2.2±0.65 UN/ml 
(p<0.01); Cystetine C of 1.74±0.13 mg/L; mean ejection fraction(EF) of 42±2.77%; uric acid 
level 235.5±113.5 mmol/L total cholesterol – 7.95±3.37 mmol/L; triglycerides 2.19 mmol/L, and 
0.07 g/l proteins in urine. Compared with participants with an estimated GFR ≥60 ml/min, those 
with estimated GFR <60 ml/min had an increased rate of subclinical primary hypothyroidism, 
higher levels of uric acid, total cholesterol and triglycerides. 
Conclusions. Our results suggest that subclinical hypothyroidism is associated not only with 
heart failure but also with CKD, and may be considered as a novel risk factor of reduced renal 
function. Further studies are needed to better understand the causal implications of 
hypothyroidism in CKD patients.  
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Introduction. Statins are a class of lipid-lowering medications, also known as HMG-CoA 
reductase inhibitors. They are considered one of the most popular prescribed agents worldwide 
for treatment of hypercholesterolemia. Statins are effective drugs to reduce cardiovascular events 
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and mortality secondary to dyslipidemia. Statin therapy is considered as the standard 
dyslipidemia therapy. Except lipid-lowering effect, it is known that statins have cholesterol-
independent effects (pleiotropic effects). 
Aim of the study. This review was undertaken to investigate the pleiotropic effects of statins on 
the metabolism of patients with cardiovascular disease. 
Material and methods. To identify relevant articles, HINARI and ScienceDirect databases were 
searched using the key-words: „statins”, „pleiotropic effects statins”, „lipophilic statins”, 
„rosuvastatin”, „atorvastatin”. 
Results. This study concluded that the pleiotropic effects of statins differ based on lipophilic 
properties. Hydrophilic statins (rosuvastatin, fluvastatin, pravastatin) are liver specific. 
Lipophilic statins (atorvastatin, lovastatin, simvastatin) are widely distributed in different tissues 
and determine a lot of side effects. Statins exhibit numerous pleiotropic effects as inhibition of 
inflammation response and oxidative stress, modulation of cell proliferation, improvement of 
endothelium function, suppression of platelet activity, plaque stability, normalization of 
sympathetic outflow, etc. The multiple pleiotropic effects of statins are due to multiple 
mechanisms, the most important one being the reduction of circulating isoprenoids and hence 
inactivation of signaling proteins. These multiple lipid-independent effects of statins are utilised 
for research in multiple treatment domains. 
Conclusions. Pleiotropic effects of statins are of major relevance in the treatment of the major 
cardiovascular conditions and diseases, such as atherosclerosis, acute coronary syndrome, 
chronic heart failure, postoperative atrial fibrillation and others. 
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Introduction. The importance of right ventricle (RV) structure and function has been always 
underestimated by physicians in their daily practice. Diastolic function of RV generally 
represents a complex process and its dysfunction is associated with pressure and volume 
overload pathologies, primary lung disease, ischemic heart disease, left ventricle dysfunction etc. 
According to the last studies, metabolic syndrome(MS) also has impact on RV structure and 
function and represents important marker of cardiovascular risk. 
Aim of the study. The aim of this study was to examine the impact of MS on RV remodeling 
and mechanics, especially diastolic function and to determine the most important parameters of 
MS for right heart remodeling. 
Materials and methods. The study included 68 subjects: 34 subjects with MS (21 women and 
13 men) and 34 controls (17 women and 17 men). There was no statistically important difference 
in the mean age between the subjects with MS and controls (p > 0.05). MS was defined by the 
presence of ≥ 3 IDF, AHA/NHLBI (2009) criteria. All subjects underwent complete two-
dimensional echocardiography and laboratory blood tests. We determined the ratio of early and 
late diastolic tricuspid flow velocities/(E/A) and the ratio of early diastolic tricuspid and septal 
tricuspid annuli flow velocity (E/e’). Assessment of RV systolic or diastolic function was based 
on the recommendation of the European Society of Echocardiography 2015. Also 
anthropometric measures (height, weight, waist circumference) were taken from all the subjects 
included in the study. 
